Abstract:Rheumatoid arthritis is an autoimmune disease that primarily affects the limbs, but the pathogenic mechanism remains unclear. γδ T cells, a T-cell subpopulation, are characterized by multiple biological functions and associated with a variety of diseases. This study investigated the antigen-presenting effects of γδ T cells and their relationship with rheumatoid arthritis development. We found that Vγ9Vδ2 T cells (the predominant subtype of γδ T cells in peripheral blood) were activated by isopentenyl pyrophosphate to continuously proliferate and differentiate into effector memory cells. The effector memory Vγ9Vδ2 T cells exhibited phenotypic characteristics of specific antigen-presenting cells, including high HLA-DR and CD80/86 expression. These Vγ9Vδ2 T cells could present soluble antigens and synthetic peptides to CD4 + T cells. Vγ9Vδ2 T cells with different phenotypes showed different cytokine secretion patterns. Effector memory Vγ9Vδ2 T cells simultaneously secreted not only interferon (IFN)-γ but also IL-17. The peripheral blood and joint synovial fluid from RA patients contained numerous heterogeneous γδ T cells that were predominantly effector memory Vγ9Vδ2 T cells with the ability to secrete inflammatory factors. We also found that γδ T cells had a similar antigen-presenting capability to B cells. These results suggest that during the development of rheumatoid arthritis, γδ T cells can aggravate immune dysfunction and produce abnormal immune damage by secreting cytokines and inducing inflammatory cells to participate in synergistic inflammatory responses. Furthermore, γδ T cells can behave similarly to B cells to present viral peptides and autoantigen peptides to CD4 + T cells, thus sustaining CD4 + T-cell activation.

The recent progress of γδ T cells and its targeted therapies in rheumatoid arthritis

Targeted Drug Delivery Strategies for the Treatment of Rheumatoid Arthritis

Epidermal growth factor receptor (EGFR) as a therapeutic target in rheumatoid arthritis

Antigen-presenting Effects of Effector Memory Vγ9Vδ2 T Cells in Rheumatoid Arthritis

Antigen-presenting effects of effector memory V|[ggr]|9V|[dgr]|2 T cells in rheumatoid arthritis

Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis

Immunomodulatory role of T helper cells in rheumatoid arthritis

Research Progress in Immunology of Rheumatoid Arthritis

Rheumatoid arthritis: pathogenesis and therapeutic advances

Dysfunctions, Molecular Mechanisms, and Therapeutic Strategies of Regulatory T Cells in Rheumatoid Arthritis

Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives

Overview of mechanisms and novel therapies on rheumatoid arthritis from a cellular perspective

Exploring the therapeutic potential of regulatory T cell in rheumatoid arthritis: Insights into subsets, markers, and signaling pathways

New Targets in Rheumatoid Arthritis Therapy and the Related Drugs

G-Protein-Coupled Receptors in Rheumatoid Arthritis: Recent Insights into Mechanisms and Functional Roles

Roles of T Cells in the Pathogenesis of Autoimmune Diseases

Roles of γδ T cells in the pathogenesis of autoimmune diseases.

Augmenting regulatory T cells: new therapeutic strategy for rheumatoid arthritis

Immunotherapy of Rheumatoid Arthritis Targeting Inflammatory Cytokines and Autoreactive T Cells

Cell-Based Therapy and Genome Editing as Emerging Therapeutic Approaches to Treat Rheumatoid Arthritis

Function and Role of Regulatory T Cells in Rheumatoid Arthritis